Skip to content
2000
Volume 18, Issue 37
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Nausea and vomiting are common gastrointestinal symptoms following opioid administration, for either chronic or acute pain management. As a consequence, patients’ dissatisfaction has a negative impact on treatment efficacy. A number of mechanisms have been identified, involving both central and peripheral sites. This article will review the pathophysiology of opioid-induced nausea and vomiting and the various pharmacological treatments currently available for its management. Preventive strategies and therapeutic approaches are evaluated in the perioperative setting and in chronic pain. Newer drugs include second generation serotonin receptor antagonists (palonosetron) and neurokinin-1 (NK-1) antagonists (aprepitant).

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161212803582540
2012-12-01
2025-01-15
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161212803582540
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test